European Neuropsychopharmacology

Article	Citations
Stress resilience during the coronavirus pandemic	271
Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables	236
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across waves	211
Results of the COVID-19 mental health international for the general population (COMET-G) study	81
Adolescent cannabis use, cognition, brain health and educational outcomes: A review of the evidence	81
Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study	64
The role of prebiotics in cognition, anxiety, and depression	61
Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis	58
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience	58
Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis	51
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance	48
Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses	46
Stratified psychiatry: Tomorrow's precision psychiatry?	42
Brain-immune crosstalk in the treatment of major depressive disorder	42
A role for the right dorsolateral prefrontal cortex in enhancing regulation of both craving and negative emotions in internet gaming disorder: A randomized trial	39
Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses - European consensus on assessment and perspectives	39
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials	38
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression	38
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice	38
Outreach and support in South-London (OASIS) 2001—2020: Twenty years of early detection, prognosis and preventive care for young people at risk of psychosis	37
Predicting differential diagnosis between bipolar and unipolar depression with multiple kernel learning on multimodal structural neuroimaging	36
Transcranial direct current stimulation in Autism Spectrum Disorder: A systematic review and meta-analysis	34
Sleep in adults with autism spectrum disorder and attention deficit/hyperactivity disorder: A systematic review and meta-analysis	31
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning	31
Epidemiology and costs of depressive disorder in Spain: the EPICO study	31

How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphet	30
A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders	30
Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions	30
Predictors of serious suicidal behavior in late-life depression	30
Anterior cingulate cortex neurometabolites in bipolar disorder are influenced by mood state and medication: A meta-analysis of 1H-MRS studies	30
Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection	29
Trajectory of cognitive impairments over 1 year after COVID‐19 hospitalisation: Pattern, severity, and functional implications	29
Cognitive modelling to assess decision-making impairments in patients with current depression and with/without suicide history	29
Depression and inflammation: Correlation between changes in inflammatory markers with antidepressant response and long-term prognosis	29
Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder	27
Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls	27
Experiences with medical cannabis in the treatment of veterans with PTSD: Results from a focus group discussion	26
Digital phenotyping and the COVID-19 pandemic: Capturing behavioral change in patients with psychiatric disorders	26
Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats	26
No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial	26
Bipolar disorder cohort studies: Crucial, but underfunded	26
Application of transcranial magnetic stimulation for major depression: Coil design and neuroanatomical variability considerations	26
Social interaction reward: A resilience approach to overcome vulnerability to drugs of abuse	26
Precision psychiatry: Complex problems require complex solutions	25
Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder	25
Central levels of tryptophan metabolites in subjects with bipolar disorder	24
Rethinking ketamine and esketamine action: Are they antidepressants with mood-stabilizing properties?	24
Oxytocin increases the pleasantness of affective touch and orbitofrontal cortex activity independent of valence	24
Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex	24
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis – A narrative review from the ECNP bipolar disorders network	24
The elephant in the room: Medication as confounder	23
Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD	23
Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress	23
Possible therapeutic applications of cannabis in the neuropsychopharmacology field	22
Stimulation of the vagus nerve reduces learning in a go/no-go reinforcement learning task	22
Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challe	22
The functioning assessment short test (FAST) applied to first-episode psychosis: Psychometric properties and severity thresholds	21
Can we expect a rise in suicide rates after the Covid-19 pandemic outbreak?	21
A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in	21
Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression	21
Identifying clinical clusters with distinct trajectories in first-episode psychosis through an unsupervised machine learning technique	20
EEG biomarker informed prescription of antidepressants in MDD: a feasibility trial	20
Suicide-related thoughts and behavior and suicide death trends during the COVID-19 in the general population of Catalonia, Spain	20
Symptom networks in acute depression across bipolar and major depressive disorders: A network analysis on a large, international, observational study	20
Multi-omics data integration methods and their applications in psychiatric disorders	20
A case-control study of the locus coeruleus degeneration in Alzheimer's disease	20
A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response	20
Changes in endogenous oxytocin levels after intranasal oxytocin treatment in adult men with autism: An exploratory study with long-term follow-up	19
Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig	19
Maternal immune activation in rats attenuates the excitability of monoamine-secreting neurons in adult offspring in a sex-specific way	19
Neurobiological mechanisms underlying cannabis-induced memory impairment	19
Shaping therapeutic trajectories in mental health: Instructive vs. permissive causality	19
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients	19
Induction of inducible nitric oxide synthase expression in activated microglia and astrocytes following pre- and postnatal immune challenge in an animal model of schizophrenia	19
Increased thin-spine density in frontal cortex pyramidal neurons in a genetic rat model of schizophrenia-relevant features	18

Therapeutic potential of opioid/cannabinoid combinations in humans: Review of the evidence	18
Altered miRNA landscape of the anterior cingulate cortex is associated with potential loss of key neuronal functions in depressed brain	18
Cognitive heterogeneity is a key predictor of differential functional outcome in patients with bipolar disorder	18
The polysemous concepts of psychomotricity and catatonia: A European multi-consensus perspective	18
Brain correlates of subjective cognitive complaints in COVID-19 survivors: A multimodal magnetic resonance imaging study	18
Comparative outcomes in electroconvulsive therapy (ECT): A naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia	18
Depression, antidepressants, and insulin resistance: which link?	17
Sex differences in the antidepressant-like potential of repeated electroconvulsive seizures in adolescent and adult rats: Regulation of the early stages of hippocampal neurogenesis	17
Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016	17
Dissecting the role of CB1 and CB2 receptors in cannabinoid reward versus aversion using transgenic CB1- and CB2-knockout mice	17
Sigma-1 (σ1) receptor activity is necessary for physiological brain plasticity in mice	17
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action	17
Comparative effects of (S)-ketamine and racemic (R/S)-ketamine on psychopathology, state of consciousness and neurocognitive performance in healthy volunteers	17
Ca2+ channel dynamics explain the nonlinear neuroplasticity induction by cathodal transcranial direct current stimulation over the primary motor cortex	17
Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188	16
Gray matter volume of rostral anterior cingulate cortex predicts rapid antidepressant response to ketamine	16
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial	16
The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study	16
Prevention of suicide by clozapine in mental disorders: systematic review	16
Wandering minds in attention-deficit/hyperactivity disorder and borderline personality disorder	16
Charting the proteome landscape in major psychiatric disorders: From biomarkers to biological pathways towards drug discovery	16
GENOME-WIDE ANALYSES OF ADHD IDENTIFY 27 RISK LOCI, REFINE THE GENETIC ARCHITECTURE AND IMPLICATE SEVERAL COGNITIVE DOMAINS	16
Registry-based studies: What they can tell us, and what they cannot	16
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings	16
Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus	16
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations	16
Slower perception of time in depressed and suicidal patients	16
Pretreatment qEEG biomarkers for predicting pharmacological treatment outcome in major depressive disorder: Independent validation from the NeuroPharm study	16
Moving forward: distinct sensorimotor abnormalities predict clinical outcome after 6 months in patients with schizophrenia	16
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errors	16
Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?	15
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility	15
Lower levels of glutathione in the anterior cingulate cortex associate with depressive symptoms and white matter hyperintensities in COVID-19 survivors	15
The impact of sex and cannabis on clinical features in first–admitted patients with psychosis	14
Cognitive reserve in mental disorders	14
Genetic origins of suicidality? A synopsis of genes in suicidal behaviours, with regard to evidence diversity, disorder specificity and neurodevelopmental brain transcriptomics	14
Anatomic abnormalities of hippocampal subfields in never-treated and antipsychotic-treated patients with long-term schizophrenia	14
Structural and functional brain abnormalities in misophonia	14
Associations between selective serotonin reuptake inhibitors and violent crime in adolescents, young, and older adults – a Swedish register-based study	14
Add-on benzodiazepine treatment in patients with major depressive disorder – results from a European cross-sectional multicenter study	14
A diet-induced gut microbiota component and related plasma metabolites are associated with depressive-like behaviour in rats	14
Differences in the prophylactic effect of serum lithium levels on depression and mania in bipolar disorder: A dose-response meta-analysis	14
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs	14
Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases	14
Systematic comparison of duration of untreated illness versus duration of untreated psychosis in relation to psychopathology and dysfunction in the Cavan-Monaghan first episode psychosis study (CAMFEP	14
Serum endocannabinoid levels in suicide attempters: A pilot study	13
Welfare consequences for people diagnosed with attention deficit hyperactivity disorder (ADHD): A matched nationwide study in Denmark	13
Epigenetic GrimAge acceleration and cognitive impairment in bipolar disorder	13
An increase in IL-6 levels at 6-month follow-up visit is associated with SSRI-emergent suicidality in high-risk children and adolescents treated with fluoxetine	13
The impact of the COVID-19 pandemic on eating disorders: A paradigm for an emotional post-traumatic stress model of eating disorders	13
Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise	13
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis	13
EXOME SEQUENCING IN BIPOLAR DISORDER REVEALS SHARED RISK GENE AKAP11 WITH SCHIZOPHRENIA	13
Precision psychotherapy	13
Neurobiology of suicide in times of social isolation and loneliness	13
Neurocognitive functions in persistent negative symptoms following a first episode of psychosis	13
Mood instability – A new outcome measure in randomised trials of bipolar disorder?	13
Region-specific and dose-specific effects of chronic haloperidol exposure on [3H]-flumazenil and [3H]-Ro15-4513 GABAA receptor binding sites in the rat brain	13
Omega-3 fatty acids during adolescence prevent schizophrenia-related behavioural deficits: Neurophysiological evidences from the prenatal viral infection with PolyI:C	13
Task experience eliminates catecholaminergic effects on inhibitory control – A randomized, double-blind cross-over neurophysiological study	12
Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled study	12
A high-resolution fMRI approach to characterize functionally distinct neural pathways within dopaminergic midbrain and nucleus accumbens during reward and salience processing	12
Neuroscience-based nomenclature of psychotropics: Progress report	12
How to reduce and stop psychiatric medication	12
Psychotherapeutic interventions specifically developed for NSSI in adolescence: A systematic review	12
Well-being, resilience and post-traumatic growth in the era of Covid-19 pandemic	12
Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling	12
A review and meta-analysis of gene expression profiles in suicide	12
Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies	12
Early life stress and glutamate neurotransmission in major depressive disorder	12
Differential reinforcement learning responses to positive and negative information in unmedicated individuals with depression	12
Polygenic risk scores in psychiatry – Large potential but still limited clinical utility	11
Reward processing in major depressive disorder and prediction of treatment response – Neuropharm study	11
Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism	11
Chronic exposure to glucocorticoids induces suboptimal decision-making in mice	11
Effects of quetiapine on sleep: A systematic review and meta-analysis of clinical trials	11
Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies	11
Suicide in the COVID-19 pandemic: What we learnt and great expectations	11
The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years	11
Oxytocin blood concentrations in alcohol use disorder: A cross-sectional, longitudinal, and sex-separated study	11

Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs – A study based on blood sample analyses from 24,239 patients	11
Ketamine and esketamine for crisis management in patients with depression: Why, whom, and how?	10
Metabolic predictors for mortality among patients treated with long-term clozapine – A longitudinal study	10
The effects of JNJ-39393406 a positive allosteric nicotine modulator on mood and cognition in patients with unipolar depression: A double-blind, add-on, placebo-controlled trial	10
Region-specific effects of acute haloperidol in the human midbrain, striatum and cortex	10
Diabetes complication burden and patterns and risk of mortality in people with schizophrenia and diabetes: A population-based cohort study with 16-year follow-up	10
Aripiprazole monotherapy as transdiagnostic intervention for the treatment of mental disorders: An umbrella review according to TRANSD criteria	10
Ayahuasca's therapeutic potential: What we know – and what not	10
Do effects of methylphenidate on cognitive performance last beyond treatment? A randomized placebo-controlled trial in boys and men with ADHD	10
Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis	10
Emotional cognition subgroups in mood disorders: Associations with familial risk	10
The role of metformin as a treatment for neuropsychiatric illness	10
Sex-dependent grades of haematopoietic modulation in patients with major depressive episodes are associated with suicide attempts	10
Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups	10
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study	10
Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs	10
Shared transethnic genetic basis of panic disorder and psychiatric and related intermediate phenotypes	10
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies	10
The effect of intranasally administered oxytocin on observed social behavior in social anxiety disorder	10
Do cariprazine and brexpiprazole cause impulse control symptoms? A case/non-case study	10
Differential effects of social isolation rearing on glutamate- and GABA-stimulated noradrenaline release in the rat prefrontal cortex and hippocampus	10
High-dose baclofen attenuates insula activation during anticipatory anxiety in treatment-seeking alcohol dependant individuals: Preliminary findings from a pharmaco-fMRI study	10
Bidirectional associations between treatment-resistant depression and general medical conditions	10
Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects	10
Social cognition in bipolar disorder: A proxy of psychosocial function and novel treatment target?	9
Lithium	9
Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes	9
Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility	9
Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats	9
Systemic neuro-dysregulation in depression: Evidence from genome-wide association	9
Current approaches to precision medicine in psychiatry: Are we just spinning our wheels?	9
Psychiatry training in 42 European countries: A comparative analysis	9
Electroconvulsive therapy, changes in immune cell ratios, and their association with seizure quality and clinical outcome in depressed patients	9
Attention deficit hyperactivity disorder: Last in, first out - delayed brain maturation with an accelerated decline?	9
When depression is difficult to treat	9
Methylation of oxytocin related genes and early life trauma together shape the N170 response to human faces	9
Depletion of brain perivascular macrophages regulates acute restraint stress-induced neuroinflammation and oxidative/nitrosative stress in rat frontal cortex	9
Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study	9
Dysfunctional coupling of the parahippocampal cortex and inferior frontal gyrus during memory suppression in posttraumatic stress disorder	8
Zopiclone to treat insomnia in older adults: A systematic review	8
Abstinence from ethanol dependence produces concomitant cortical gray matter abnormalities, microstructural deficits and cognitive dysfunction	8
Apps for mental health care: The raise of digital psychiatry	8
A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder	8
Anxiolytic–like activity of 5–methoxyflavone in mice with involvement of GABAergic and serotonergic systems - in vivo and in silico evidences	8
Similarities and dissimilarities in the effects of benzodiazepines and specific serotonin reuptake inhibitors (SSRIs) in the defensive marble burying test: A systematic review and meta-analysis	8
Primary role for melatonin MT2 receptors in the regulation of anhedonia and circadian temperature rhythm	8
Antidepressant discontinuation syndrome: A state-of-the-art clinical review	8
Promoting good mental health in the whole population: The new frontier	8
Neuronal and cognitive predictors of improved executive function following action-based cognitive remediation in patients with bipolar disorder	8
Prelimbic medial prefrontal cortex disruption during adolescence increases susceptibility to helpless behavior in adult rats	8
Neuropeptide Y, calcitonin gene-related peptide, and neurokinin A in brain regions of HAB rats correlate with anxiety-like behaviours	8
The effects of transient receptor potential cation channel inhibition by BI 1358894 on cortico-limbic brain reactivity to negative emotional stimuli in major depressive disorder	8
Self-reported neurocognitive symptoms during COVID-19 lockdown and its associated factors in a sample of psychiatric patients. Results from the BRIS-MHC study	8
Why primary prevention often is no prevention at all	8
Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art	8
Immune-related biomarkers and suicidal behaviors: A meta-analysis	8
Lithium: What can we do to overcome the discrepancies between evidence, guideline recommendations and clinical practice?	8
Ketamine treatment upon memory retrieval reduces fear memory in marmoset monkeys	8
Autoimmune encephalitis or autoimmune psychosis?	8
Social Stress in Bipolar Disorder	8
Comparative effectiveness of antipsychotic monotherapy and polypharmacy in schizophrenia patients with clozapine treatment: A nationwide, health insurance data-based study	8
Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder	8
Precision psychiatry: The complexity of personalizing antipsychotic dosing	8
Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders	7
Factors associated with laxative use in schizophrenia patients treated with second-generation antipsychotics	7
Integrating genomics and transcriptomics: Towards deciphering ADHD	7
Lentiviral-mediated up-regulation of let-7d microRNA decreases alcohol intake through down-regulating the dopamine D3 receptor	7
The black sheep of the family- whole-exome sequencing in family of lithium response discordant bipolar monozygotic twins	7
Early intervention comes late	7
Effect of the C-reactive protein gene on risk and clinical characteristics of schizophrenia in winter-born individuals	7
THE FEMALE PROTECTIVE EFFECT AGAINST AUTISM SPECTRUM DISORDER	7
Different baseline physical activity predicts susceptibility and resilience to chronic social defeat stress in mice: Involvement of dopamine neurons	7
Biological markers of sex-based differences in major depressive disorder and in antidepressant response	7
Social deprivation substantially changes multi-structural neurotransmitter signature of social interaction: Glutamate concentration in amygdala and VTA as a key factor in social encounter-induced 50-k	7
Transcriptome profiling in adult attention-deficit hyperactivity disorder	7
Sucrose preference test: A systematic review of protocols for the assessment of anhedonia in rodents	7
Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransm	7
What can lifestyle factors tell us about cognitive dysfunction in bipolar disorder?	7
The impact of the Covid-19 pandemic on patients with schizophrenia	7
The transition from adolescence to adulthood in patients with schizophrenia: Challenges, opportunities and recommendations	7
Longitudinal alterations in mRNA expression of the BDNF neurotrophin signaling cascade in blood correlate with changes in depression scores in patients undergoing electroconvulsive therapy	7
The potential of psychedelics for the treatment of Alzheimer's disease and related dementias	7
Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review	7
Toward the “helioscope” hypothesis of psychedelic therapy	7
Reinforcement learning abnormalities in the attenuated psychosis syndrome and first episode psychosis	7
Neuroimaging evidence for structural correlates in adolescents resilient to polysubstance use: A five-year follow-up study	7
DNA methylation in the 5-HTT regulatory region is associated with CO2-induced fear in panic disorder patients	7
Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study	7
Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction	7
Neural underpinnings of emotion regulation subgroups in remitted patients with recently diagnosed bipolar disorder	7
α2A- and α2C-adrenoceptor expression and functionality in postmortem prefrontal cortex of schizophrenia subjects	7
Refining biomarker evaluation in ASD	7
Stress, mental disorder and ketamine as a novel, rapid acting treatment	6
Sex-specific associations of basal steroid hormones and neuropeptides with Conduct Disorder and neuroendocrine mediation of environmental risk	6
The U-shaped relationship between parental age and the risk of bipolar disorder in the offspring: A systematic review and meta-analysis	6